Alexandre Bacq, Simone Astori, Elias Gebara, Wei Tang, Bianca A Silva, Jose Sanchez-Mut, Jocelyn Grosse, Isabelle Guillot de Suduiraut, Olivia Zanoletti, Catherine Maclachlan, Graham W Knott, Johannes Gräff, Carmen Sandi
Molecular psychiatry 2020 SepAggression is frequently observed in neurodevelopmental psychiatric disorders such as schizophrenia, autism, and bipolar disorder. Due to a lack of understanding of its underlying mechanisms, effective treatments for abnormal aggression are still missing. Recently, genetic variations in Sialyltransferase 2 (St8sia2) have been linked to these disorders and aggression. Here we identify abnormal aggressive behaviors and concomitant blunted fear learning in St8sia2 knockout (-/-) mice. It is worth noting that the amygdala of St8sia2-/- mice shows diminished threat-induced activation, as well as alterations in synaptic structure and function, including impaired GluN2B-containing NMDA receptor-mediated synaptic transmission and plasticity. Pharmacological rescue of NMDA receptor activity in the amygdala of St8sia2-/- mice with the partial agonist D-cycloserine restores synaptic plasticity and normalizes behavioral aberrations. Pathological aggression and associated traits were recapitulated by specific amygdala neonatal St8sia2 silencing. Our results establish a developmental link between St8sia2 deficiency and a pathological aggression syndrome, specify synaptic targets for therapeutic developments, and highlight D-cycloserine as a plausible treatment.
Alexandre Bacq, Simone Astori, Elias Gebara, Wei Tang, Bianca A Silva, Jose Sanchez-Mut, Jocelyn Grosse, Isabelle Guillot de Suduiraut, Olivia Zanoletti, Catherine Maclachlan, Graham W Knott, Johannes Gräff, Carmen Sandi. Amygdala GluN2B-NMDAR dysfunction is critical in abnormal aggression of neurodevelopmental origin induced by St8sia2 deficiency. Molecular psychiatry. 2020 Sep;25(9):2144-2161
PMID: 30089788
View Full Text